SCOPUS 정보 검색 플랫폼

Volumn 45, Issue 9, 2001, Pages 2662-2665

Interactions of quinupristin-dalfopristin with eight other antibiotics as measured by time-kill studies with 10 strains of Staphylococcus aureus for which quinupristin-dalfopristin alone was not bactericidal

(3) Fuchs, P C a Barry, A L a Brown, S D a

a CLINICAL MICROBIOLOGY INSTITUTE (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DALFOPRISTIN PLUS QUINUPRISTIN; GENTAMICIN; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; BACTERIUM ISOLATE; CELL KILLING; CONTROLLED STUDY; DRUG ANTAGONISM; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; COLONY COUNT, MICROBIAL; DRUG INTERACTIONS; DRUG RESISTANCE, MICROBIAL; GENTAMICINS; HUMANS; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS; TIME FACTORS; VIRGINIAMYCIN;

EID: 0034878868 PISSN: 00664804 EISSN: None Source Type: Journal
DOI: 10.1128/AAC.45.9.2662-2665.2001 Document Type: Article

Times cited : (16)

References (15)

1
- 0027410883
- RP 59500, a new streptogramin, highly active against recent isolates of North American staphylococci
- (1993) Diagn. Microbiol. Infect. Dis. , vol.16 , pp. 223-226
- Archer, G.L.¹ Auger, P.² Doern, G.U.³ Ferraro, M.J.⁴ Fuchs, P.C.⁵ Jorgensen, J.H.⁶ Low, D.E.⁷ Murray, P.R.⁸ Reller, L.B.⁹ Stratton, C.W.¹⁰ Wennerstein, C.B.¹¹ Moellering R.C., Jr.¹²

2
- 0034334024
- In vitro activity of quinupristin/dalfopristin in comparison with five antibiotics against worldwide isolates of staphylococci
- (2000) Clin. Microbiol. Infect. , vol.6 , pp. 608-612
- Auckenthaler, R.¹ Courvalin, P.² Feger, C.³ Roche, G.⁴

3
- 0026773160
- In-vitro activity of RP 59500, a new semi-synthetic streptogramin antibiotic, against Grampositive bacteria
- (1992) J. Antimicrob. Chemother. , vol.30 , Issue.SUPPL. A , pp. 29-37
- Brumfitt, W.¹ Hamilton-Miller, J.M.² Shah, S.³

4
- 0030983411
- Inhibition of protein synthesis by streptograrnins and related antibiotics
- (1997) J. Antimicrob. Chemother. , vol.39 , Issue.SUPPL. A , pp. 7-13
- Cocito, C.¹ DiGiambattista, M.² Nyssen, E.³ Vanuffel, P.⁴

5
- 0002515716
- Antimicrobial combinations
- V. Lorian (ed.) Williams and Wilkins Co., Baltimore, Md.
- (1996) Antibiotics in laboratory medicine, 4th ed. , pp. 330-396
- Eliopoulos, G.M.¹ Moellering R.C., Jr.²

6
- 0029072505
- Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500
- (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 1419-1424
- Entenza, J.M.¹ Drugeon, H.² Glauser, M.P.³ Moreillon, P.⁴

7
- 0028890892
- Critical influence of resistance to streptogramin B-type antibiotics on the activity of RP 59500 (quinupristin-dalfopristin) in experimental endocarditis due to Staphylococcus aureus
- (1995) Antimicrob. Agents Chemother. , vol.39 , pp. 400-405
- Fantin, B.¹ Leclereq, R.² Merle, Y.³ Saint-Julien, L.⁴ Veyrat, C.⁵ Duval, J.⁶ Carbon, C.⁷

8
- 0033798007
- Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: Clindamycin susceptibility as a surrogate indicator
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 2880-2882
- Fuchs, P.C.¹ Barry, A.L.² Brown, S.D.³

9
- 0031850635
- Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada
- (1998) Diagn. Microbiol. Infect. Dis. , vol.31 , pp. 437-451
- Jones, R.N.¹ Ballow, C.H.² Biedenbach, D.J.³ Deinhart, J.A.⁴ Schentag, J.J.⁵

10
- 0345219438
- In-vitro bactericidal activity of quinupristin/dalfopristin alone and in combination against resistant strains of Enterococcus species and Staphylococcus aureus
- (1997) J. Antimicrob. Chemother. , vol.39 , pp. 33-39
- Kang, S.L.¹ Rybak, M.J.²

11
- 0026684265
- RP 59500, a new parenteral semisynthetic streptogramin, against staphylococci with various mechanisms of resistance to macrolide-lincosamide-streptogramin antibiotics
- (1992) J. Antimicrob. Chemother. , vol.30 , Issue.SUPPL. A , pp. 67-75
- Leclercq, R.¹ Nantas, L.² Soussy, C.J.³ Duva, J.⁴

12
- 0003922953
- National Committee for Clinical Laboratory Standards, Wayne, Pa.
- (1998) Methods for determining bactericidal activity of antimicrobial agents. Approved guideline M26-A

13
- 0026741441
- The in vitro activity of new streptogramins, and RP 59500, RP 57669, and RP 54476, alone and in combination
- (1992) J. Antimicrob. Chemother. , vol.30 , Issue.SUPPL. A , pp. 83-94
- Neu, H.C.¹ Chin, N.² Gu, J.³

14
- 0026689993
- In vitro activity of RP 59500, a semisynthetic streptogramin, against staphylococci and streptococci
- (1992) J. Antimicrob. Chemother. , vol.30 , Issue.SUPPL. A , pp. 15-18
- Pechère, J.C.¹

15
- 0033933606
- Quinupristin-dalfopristin combined with β-lactams for treatment of experimental endocarditis due to Staphylococcus aureus constitutively resistant to macrolide-lincosamide-streptogramin B antibiotics
- (2000) Antimicrob. Agents Chemother. , vol.44 , pp. 1789-1795
- Vouillamoz, J.¹ Entenza, J.M.² Féger, C.³ Glauser, M.P.⁴ Moreillon, P.⁵

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.